Chuck Darwin on Nostr: Robert F. Kennedy Jr., Trump’s nominee to run the Department of Health and Human ...
Robert F. Kennedy Jr.,
Trump’s nominee to run the Department of Health and Human Services, which oversees the NIH,
has said he wants to fire and replace 600 of the agency’s 20,000 employees
and shift research away from infectious diseases and vaccines,
which are at the core of NIAID’s mission to understand, treat and prevent infectious, immunologic and allergic diseases.
He has said that half of NIH’s budget should focus on “preventive, alternative and holistic approaches to health.”
He has a particular interest in improving diets.
Even the most staunch defenders of NIH agree the agency could benefit from reforms.
Some would like to see fewer institutes,
while others believe there should be term limits for directors.
There are important debates over whether to fund and how to oversee controversial research methods,
and concerns about the way the agency has handled transparency.
Scientists inside and outside of the institute agree that work needs to be done to restore public trust in the agency.
But experts and patient advocates worry that an overhaul or dismantling of NIAID
without a clear understanding of the critical work performed there
could imperil not only the development of future lifesaving treatments
but also the nation’s place at the helm of biomedical innovation.
https://www.propublica.org/article/nih-niaid-trump-kennedy-bhattacharya-vaccines-research
Trump’s nominee to run the Department of Health and Human Services, which oversees the NIH,
has said he wants to fire and replace 600 of the agency’s 20,000 employees
and shift research away from infectious diseases and vaccines,
which are at the core of NIAID’s mission to understand, treat and prevent infectious, immunologic and allergic diseases.
He has said that half of NIH’s budget should focus on “preventive, alternative and holistic approaches to health.”
He has a particular interest in improving diets.
Even the most staunch defenders of NIH agree the agency could benefit from reforms.
Some would like to see fewer institutes,
while others believe there should be term limits for directors.
There are important debates over whether to fund and how to oversee controversial research methods,
and concerns about the way the agency has handled transparency.
Scientists inside and outside of the institute agree that work needs to be done to restore public trust in the agency.
But experts and patient advocates worry that an overhaul or dismantling of NIAID
without a clear understanding of the critical work performed there
could imperil not only the development of future lifesaving treatments
but also the nation’s place at the helm of biomedical innovation.
https://www.propublica.org/article/nih-niaid-trump-kennedy-bhattacharya-vaccines-research